At the highest dose of HDACi (30μM), expression of NCF2 was elevated 2.13 fold and PDLIM1 was decreased 0.63 fold to that of vehicle-treated FA cells (Fig 7A). The gene discussed is NCF2; the disease is Friedreich ataxia.